Loading
Rayonier Advanced Materials Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Bloomquist DeLyle W, was filed 14 Aug 2025.
Rayonier Advanced Materials Inc.: what insiders have been doing
This page follows insider dealings at Rayonier Advanced Materials Inc. as filed with SEC (Form 4), a company from the Chemicals & Materials sector based in Riverplace Tower, United States. The group dates from 2014. The last twelve months, up to 22 October 2026, brought 43 filings signed by 16 insiders.
No insider bought on the market over the period, while 1 insider filed 1 sale totalling €15k. One trade stands out by size: a sale of €15k from Palumbo Lisa M, disclosed on 11 August 2026, or 0.0030% of market capitalisation.
Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Across the 2,023 companies tracked on its exchange, the median is 41 filings; at 43 filings, this issuer sits above that mark. Since 2016, the database holds 24 purchases and 12 sales by insiders of the company. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 1.47 bn USD and net income of -420.7 m USD.
Elsewhere in the same sector, our signals recently picked up insider purchases at Fuller H B Co and Gold.com, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
369
Thresholds
n/a
Buy Volume
€2M
24 ops. · all time
Sell Volume
€190,492
12 ops. · all time
Who traded when
BuySaleDeLyle W. Bloomquist2 buys
Eric Bowen1 buy
Lisa M. Palumbo1 sale
Since the insiders bought
- +61.6%Entry US$5.15 · Close at T+365 US$8.32
- -25.2%Entry US$7.66 · Close at T+365 US$5.73
- +55.4%Entry US$3.63 · Close at T+365 US$5.64
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Rayonier Advanced Materials Inc. Buy (bullish), based on 2 analysts. Average price target: US$14.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 24,619 of 26,248 companies
17.1
score / 100
Value25
Quality9
FCF yld-19%
Earn yld-89%
EV/EBITDA9.2x
ROE-50%
Gross mgn8.1%
Net mgn-29%
Debt/EBITDA5.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$7.00
Analyst consensus
2 analystsBuy
US$13.00Target US$14.00(+100%)US$15.00
Income statement
RevenueUS$1.5B
Gross profitUS$118.8M8% margin
EBITDAUS$136.9M9% margin
Net income-US$422.5M-9.5% margin
Valuation
PER (forward)5.9x
P/Book2.4x
Beta1.84
Balance sheet & cash
Market capUS$473.5M
Total debtUS$779M
Free Cash Flow-US$91.7M
Debt / Equity374%
Profitability & ownership
ROE-49.7%
ROA0.2%
% insiders5.0%
% institutions78.4%
Last declaration on 11 August 2026
Declarations369 total
1,931.487 shares@ US$9.130.0030% mcap25.3% of flowCommon StockSEC:0001225208-26-007070:0
16,429 shares0Common StockSEC:0001225208-26-005383:0
16,429 shares0Common StockSEC:0001225208-26-005382:0
16,429 shares0Common StockSEC:0001225208-26-005381:0
16,429 shares0Common StockSEC:0001225208-26-005380:0
16,429 shares0Common StockSEC:0001225208-26-005379:0
16,429 shares0Common StockSEC:0001225208-26-005385:0
16,429 shares0Common StockSEC:0001225208-26-005378:0
16,429 shares0Common StockSEC:0001225208-26-005384:0
10,572 shares@ US$9.378.6% of flowCommon StockSEC:0001225208-26-003282:1
611 shares@ US$9.3731.5% of flowCommon StockSEC:0001225208-26-003285:1
2,180 shares@ US$9.378.8% of flowCommon StockSEC:0001225208-26-003280:1
732 shares@ US$9.3731.5% of flowCommon StockSEC:0001225208-26-003279:1
3,264 shares@ US$9.3723.8% of flowCommon StockSEC:0001225208-26-003284:1
4,206 shares@ US$9.3712.5% of flowCommon StockSEC:0001225208-26-003278:1
570 shares@ US$9.3731.5% of flowCommon StockSEC:0001225208-26-003281:1
13,434 shares0Common StockSEC:0001225208-26-003284:0
4,113 shares0Common StockSEC:0001225208-26-003283:0
2,468 shares0Common StockSEC:0001225208-26-003279:0
10,366 shares@ US$9.47100.0% of flowCommon StockSEC:0001225208-26-003276:0
4,480 shares@ US$9.47100.0% of flowCommon StockSEC:0001225208-26-003275:0
2,058 shares0Common StockSEC:0001225208-26-003285:0
26,866 shares0Common StockSEC:0001225208-26-003282:0
1,920 shares0Common StockSEC:0001225208-26-003281:0
4,113 shares0Common StockSEC:0001225208-26-003280:0
25 of 369 declarations
About Rayonier Advanced Materials Inc.
Rayonier Advanced Materials Inc. (RYAM) is a U.S.-listed company traded on the NYSE/NASDAQ market in the United States, with its corporate headquarters in Jacksonville, Florida. The company is a global leader in cellulose and derivatives, serving technically demanding end markets such as filters, food, pharmaceuticals, high-performance plastics, propellants, and other industrial applications. Its operating heritage dates back more than 95 years, reflecting a long industrial lineage in wood-based and pulp-related materials. ([investors.ryam.com](https://investors.ryam.com/overview/default.aspx))
RYAM’s business model is centered on specialized cellulose products rather than broad commodity chemicals. Its main product families include cellulose specialties, cellulose commodities, cellulose viscose pulp, cellulose fluff pulp, high-yield pulp, and value-added derivatives such as paperboard, biofuels, bioelectricity, and lignin. The company also describes biomaterials as an important growth vector, as it seeks to expand into renewable, higher-value applications. Manufacturing assets are located in the United States, Canada, and France, and the company sells into more than 40 countries, giving it a genuinely international footprint. ([investors.ryam.com](https://investors.ryam.com/overview/default.aspx))
Read moreShow less
From a competitive standpoint, RYAM occupies a specialist niche with meaningful technical barriers. Its position is supported by dedicated industrial capacity, process know-how in high-purity cellulose, and diversified downstream uses that touch consumer, pharmaceutical, and industrial supply chains. This niche positioning can support pricing power in certain products, but the business remains exposed to raw-material inflation, logistics costs, cyclical demand patterns, and trade-policy volatility. The company explicitly highlights tariff and cross-border trade risks, particularly involving China, Canada, and Mexico. ([investors.ryam.com](https://investors.ryam.com/files/doc_financials/2024/ar/2025-03-28_2024_Annual_Report_-_Final_for_webhosting.pdf))
Recent developments point to an ongoing portfolio transition. RYAM reported 2025 revenue of $1.5 billion, adjusted EBITDA of $133 million, and adjusted net debt of about $745 million at year-end 2025. Management also described 2025 as a challenging year, with mixed demand conditions and segment restructuring within High Purity Cellulose. A key operational event was the indefinite suspension of the Temiscaming plant in July 2024, followed by the permanent cessation of DWP production in the first quarter of 2026. In parallel, RYAM continues to invest in biomaterials, including projects in France, as it works to diversify earnings and strengthen long-term profitability. ([investors.ryam.com](https://investors.ryam.com/overview/default.aspx))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
